Jafron Biomedical Co.,Ltd.

SZSE:300529 Stock Report

Market Cap: CN¥23.7b

Jafron BiomedicalLtd Dividends and Buybacks

Dividend criteria checks 3/6

Jafron BiomedicalLtd is a dividend paying company with a current yield of 1.28% that is well covered by earnings.

Key information

1.3%

Dividend yield

1.1%

Buyback Yield

Total Shareholder Yield2.4%
Future Dividend Yield3.1%
Dividend Growth17.7%
Next dividend pay daten/a
Ex dividend daten/a
Dividend per shareCN¥0.400
Payout ratio39%

Recent dividend and buyback updates

Jafron BiomedicalLtd's (SZSE:300529) Dividend Will Be Reduced To CN¥0.40

May 28
Jafron BiomedicalLtd's (SZSE:300529) Dividend Will Be Reduced To CN¥0.40

Recent updates

Earnings Report: Jafron Biomedical Co.,Ltd. Missed Revenue Estimates By 8.1%

Oct 21
Earnings Report: Jafron Biomedical Co.,Ltd. Missed Revenue Estimates By 8.1%

Further Upside For Jafron Biomedical Co.,Ltd. (SZSE:300529) Shares Could Introduce Price Risks After 34% Bounce

Oct 02
Further Upside For Jafron Biomedical Co.,Ltd. (SZSE:300529) Shares Could Introduce Price Risks After 34% Bounce

Estimating The Fair Value Of Jafron Biomedical Co.,Ltd. (SZSE:300529)

Sep 09
Estimating The Fair Value Of Jafron Biomedical Co.,Ltd. (SZSE:300529)

The Returns On Capital At Jafron BiomedicalLtd (SZSE:300529) Don't Inspire Confidence

Aug 25
The Returns On Capital At Jafron BiomedicalLtd (SZSE:300529) Don't Inspire Confidence

Jafron BiomedicalLtd's (SZSE:300529) Dividend Will Be Reduced To CN¥0.40

May 28
Jafron BiomedicalLtd's (SZSE:300529) Dividend Will Be Reduced To CN¥0.40

A Look At The Intrinsic Value Of Jafron Biomedical Co.,Ltd. (SZSE:300529)

May 24
A Look At The Intrinsic Value Of Jafron Biomedical Co.,Ltd. (SZSE:300529)

Why Investors Shouldn't Be Surprised By Jafron Biomedical Co.,Ltd.'s (SZSE:300529) 30% Share Price Surge

May 08
Why Investors Shouldn't Be Surprised By Jafron Biomedical Co.,Ltd.'s (SZSE:300529) 30% Share Price Surge

Jafron BiomedicalLtd's (SZSE:300529) Soft Earnings Don't Show The Whole Picture

May 02
Jafron BiomedicalLtd's (SZSE:300529) Soft Earnings Don't Show The Whole Picture

Investors Could Be Concerned With Jafron BiomedicalLtd's (SZSE:300529) Returns On Capital

Apr 13
Investors Could Be Concerned With Jafron BiomedicalLtd's (SZSE:300529) Returns On Capital

Does Jafron BiomedicalLtd (SZSE:300529) Have A Healthy Balance Sheet?

Mar 22
Does Jafron BiomedicalLtd (SZSE:300529) Have A Healthy Balance Sheet?

Jafron Biomedical Co.,Ltd.'s (SZSE:300529) P/E Is Still On The Mark Following 31% Share Price Bounce

Mar 04
Jafron Biomedical Co.,Ltd.'s (SZSE:300529) P/E Is Still On The Mark Following 31% Share Price Bounce

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: 300529 has been paying a dividend for less than 10 years and during this time payments have been volatile.

Growing Dividend: 300529's dividend payments have increased, but the company has only paid a dividend for 7 years.


Dividend Yield vs Market

Jafron BiomedicalLtd Dividend Yield vs Market
How does 300529 dividend yield compare to the market?
SegmentDividend Yield
Company (300529)1.3%
Market Bottom 25% (CN)0.6%
Market Top 25% (CN)2.2%
Industry Average (Medical Equipment)1.7%
Analyst forecast (300529) (up to 3 years)3.1%

Notable Dividend: 300529's dividend (1.28%) is higher than the bottom 25% of dividend payers in the CN market (0.56%).

High Dividend: 300529's dividend (1.28%) is low compared to the top 25% of dividend payers in the CN market (2.17%).


Earnings Payout to Shareholders

Earnings Coverage: With its reasonably low payout ratio (39.5%), 300529's dividend payments are well covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: With its reasonably low cash payout ratio (35.5%), 300529's dividend payments are well covered by cash flows.


Discover strong dividend paying companies